Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

705
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
705
Censoring Survival Data01:09

Censoring Survival Data

654
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
654
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.2K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.2K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

337
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
337
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

596
Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
596

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flexible Empirical Bayesian Approaches to Pharmacovigilance for Simultaneous Signal Detection and Signal Strength Estimation in Spontaneous Reporting Systems Data.

Statistics in medicine·2025
Same author

Visit Characteristics Associated With Pediatric Dental Appointment No-Shows in an Academic Dental Setting.

International journal of dentistry·2025
Same author

Under-Representation and Under-Reporting of Minoritized Racial and Ethnic Groups in Clinical Trials on Immune Checkpoint Inhibitors.

JCO oncology practice·2024
Same author

Topical hidden genome: discovering latent cancer mutational topics using a Bayesian multilevel context-learning approach.

Biometrics·2024
Same author

On the use of the likelihood ratio test methodology in pharmacovigilance.

Statistics in medicine·2022
Same author

Bayesian analysis of coupled cellular and nuclear trajectories for cell migration.

Biometrics·2021
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
Same journal

Subgroup Analysis of Interval-censored Failure Time Data With Application to Alzheimer's Disease.

Statistics in medicine·2026
Same journal

Rejoinder to Commentaries on "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events".

Statistics in medicine·2026
Same journal

A Multi-Stage Drop-the-Loser Design With Superiority Boundaries.

Statistics in medicine·2026
Same journal

Interpretable ROI Identification in Brain Image Analysis: Overcoming CNN Black Box Challenges With Kriging-Enhanced Adaptive Sampling.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 8, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K

A Nonparametric Bayesian Local-Global Model for Enhanced Adverse Event Signal Detection in Spontaneous Reporting

Xin-Wei Huang1, Saptarshi Chakraborty1

  • 1Department of Biostatistics, State University of New York at Buffalo, Buffalo, New York, USA.

Statistics in Medicine
|April 7, 2026
PubMed
Summary
This summary is machine-generated.

New Bayesian models improve the detection of rare adverse events (AEs) in drug safety surveillance. These methods enhance statistical power by sharing information across drugs, significantly boosting signal detection sensitivity.

Keywords:
Bayesian hierarchical modelDirichlet process prioradverse event (AE) signal detectionfalse discovery ratelocal–global modelsnon parametric Bayesian modelspharmacovigilancereal‐world evidence (RWE)

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Design and Analysis for Fall Detection System Simplification
08:05

Design and Analysis for Fall Detection System Simplification

Published on: April 6, 2020

11.3K

Related Experiment Videos

Last Updated: Apr 8, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.8K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Design and Analysis for Fall Detection System Simplification
08:05

Design and Analysis for Fall Detection System Simplification

Published on: April 6, 2020

11.3K

Area of Science:

  • Pharmacovigilance
  • Biostatistics
  • Real-world evidence (RWE)

Background:

  • Spontaneous reporting system databases are vital for post-marketing surveillance and real-world evidence (RWE) generation.
  • Current adverse event (AE) signal detection methods struggle with rare AEs or new drugs due to low statistical power.
  • Existing methods often overlook complex drug-drug associations, limiting signal detection capabilities.

Purpose of the Study:

  • To develop novel nonparametric Bayesian models for enhanced AE signal detection.
  • To capture complex between-drug associations for principled information sharing.
  • To improve statistical power and sensitivity in identifying drug-specific AEs.

Main Methods:

  • Utilized local-global mixture Dirichlet process (DP) prior-based nonparametric Bayesian models.
  • Developed efficient Markov chain Monte Carlo algorithms for model implementation.
  • Employed a false discovery rate (FDR)-controlled, false negative rate (FNR)-optimized hypothesis testing framework.

Main Results:

  • Simulations demonstrated superior sensitivity, often exceeding existing methods by twofold or more.
  • The proposed methods strictly controlled the false discovery rate (FDR).
  • Application to FDA FAERS data confirmed effectiveness in real-world AE signal detection.

Conclusions:

  • Novel Bayesian models effectively capture drug-drug associations for improved AE signal detection.
  • The methods enhance statistical power, particularly for rare adverse events and newer drugs.
  • This approach offers a significant advancement in pharmacovigilance and drug safety surveillance.